AstraZeneca
AZN
$8,582
Share price
0.50%
Change (1 day)
48.98%
Change (1 year)
Categories
Market capitalization of AstraZeneca (AZN)
Market cap: $26.608 Trillion
As of January 2026 AstraZeneca has a market cap of $26.608 Trillion. This makes AstraZeneca the world's 47th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of AstraZeneca from 1996 to 2026
End of year Market Cap
| Year | Marketcap | Change |
|---|---|---|
| 2026 | $26.608 T | 2.9% |
| 2025 | $25.857 T | 46.71% |
| 2024 | $17.624 T | 1.41% |
| 2023 | $17.380 T | -0.17% |
| 2022 | $17.409 T | 28.89% |
| 2021 | $13.506 T | 41% |
| 2020 | $9.579 T | 2.65% |
| 2019 | $9.332 T | 41.36% |
| 2018 | $6.602 T | 18.68% |
| 2017 | $5.563 T | 18.71% |
| 2016 | $4.686 T | -18.43% |
| 2015 | $5.745 T | 1.22% |
| 2014 | $5.676 T | 23.99% |
| 2013 | $4.578 T | 42.63% |
| 2012 | $3.209 T | 1.42% |
| 2011 | $3.164 T | 8.51% |
| 2010 | $2.916 T | -7.72% |
| 2009 | $3.160 T | 10.71% |
| 2008 | $2.854 T | 16.59% |
| 2007 | $2.448 T | -32.61% |
| 2006 | $3.633 T | 3.44% |
| 2005 | $3.512 T | 35.57% |
| 2004 | $2.590 T | -30.52% |
| 2003 | $3.729 T | 28.95% |
| 2002 | $2.892 T | -26.31% |
| 2001 | $3.924 T | -7.55% |
| 2000 | $4.244 T | 31.68% |
| 1999 | $3.223 T | 77.85% |
| 1998 | $1.812 T | 34.98% |
| 1997 | $1.342 T | 40.83% |
| 1996 | $953.49 B |
End of Day market cap according to different sources
On Jan 19th, 2026 the market cap of AstraZeneca was reported to be:
$26.605 Trillion
$26.608 Trillion
Market capitalization for similar companies or competitors
| Name | Marketcap | Market cap differencediff. | Country |
|---|---|---|---|
 Bristol-Myers Squibb
BMY
|
$10.223 T | -61.58% | ๐บ๐ธ USA |
 Pfizer
PFE
|
$13.254 T | -50.19% | ๐บ๐ธ USA |
 Merck
MRK
|
$24.704 T | -7.15% | ๐บ๐ธ USA |
 GSK plc
GSK
|
$8.856 T | -66.71% | ๐ฌ๐ง UK |
 Sanofi
SNY
|
$10.284 T | -61.35% | ๐ซ๐ท France |
 Eli Lilly
LLY
|
$84.600 T | 217.95% | ๐บ๐ธ USA |
 Johnson & Johnson
JNJ
|
$47.878 T | 79.94% | ๐บ๐ธ USA |
 Abbott Laboratories
ABT
|
$19.259 T | -27.62% | ๐บ๐ธ USA |
 Biogen
BIIB
|
$2.192 T | -91.76% | ๐บ๐ธ USA |
 Novartis
NVS
|
$25.170 T | -5.40% | ๐จ๐ญ Switzerland |